Vasomotor Symptoms
📧 Sign up to get email alerts when something new happens for Vasomotor Symptoms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2) [Phase 3]
Phase 3 trial update for elinzanetant in vasomotor symptoms associated with menopause; the OASIS-2 study has completed and results have been…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants [Phase 1]
Phase 1 study evaluating the relative bioavailability, safety and tolerability of single- and multiple-doses of Elinzanetant in healthy fema…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II) [Phase 3]
Phase 3 E4Comfort II trial evaluating estetrol for moderate-to-severe vasomotor symptoms in postmenopausal women has completed and results h…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally [Phase 1]
Phase 1 study evaluating pharmacokinetics, safety, and physiological effects of elinzanetant in participants with different kidney function;…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I) [Phase 3]
Phase 3 clinical trial (E4Comfort Study I) assessing estetrol for moderate to severe vasomotor symptoms in postmenopausal women has complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women [Phase 1, Phase 2]
Results from a completed Phase 1/2 trial of DARE-HRT1 over 12 weeks in healthy postmenopausal women have been posted. The study targeted vul…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause [Phase 3]
A Phase 3 trial of fezolinetant for vasomotor symptoms in menopausal women has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women [Phase 1]
A Phase 1 clinical trial update reports the completion of a study evaluating whether elinzanetant affects driving ability and brain function…
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: HIRREM Hot Flashes Study [NA]
Clinical trial update for the HIRREM hot flashes study shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms [Phase 3]
A Phase 3 trial comparing oxybutynin to paroxetine for vasomotor symptoms induced by aromatase inhibitors; efficacy and safety data are not …
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms [Phase 2]
Phase 2 long-term safety and efficacy study of MT-8554 for vasomotor symptoms in postmenopausal women has completed, with results posted in …
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer [Phase 2]
Phase 2 clinical trial investigating stellate ganglion block for hot flashes in Hispanic women with breast cancer; status terminated with re…
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the pharmacokinetics and safety of BAY3427080 (NT-814) in postmenopausal women with vasomotor symptoms; …
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms [Phase 2]
Phase 2 study evaluating RAD1901 for vasomotor symptoms in postmenopausal women was terminated; results were posted but no further developme…
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: Study of Erenumab (AMG 334) in Women With Hot Flashes [Phase 1]
Phase 1 clinical trial of erenumab (AMG 334) in women with vasomotor symptoms and hot flashes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
A postmarketing surveillance study of desvenlafaxine succinate (Pristiq) in Filipino patients with major depressive disorder and vasomotor s…
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms. [Phase 3]
A Phase 3 safety and efficacy trial evaluating a drospirenone/estradiol combination for vasomotor symptoms in postmenopausal Chinese women h…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation [NA]
Completion update for the MsFLASH-02 trial, a 3-by-2 factorial study evaluating yoga, physical exercise, and omega-3 supplementation for rel…
-
CLINICAL_TRIALS trial_result · 2014-07-30Clinical Trial Update: Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013) [Phase 3]
Phase 3 dose-finding trial assessing safety and efficacy of Org 50081 (Esmirtazapine) for vasomotor symptoms in postmenopausal menopause; st…
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012) [Phase 3]
Phase 3 dose-finding trial of Org50081 (Esmirtazapine) for vasomotor symptoms in menopause completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) [Phase 3]
Phase 3 trial results for Brisdelle (paroxetine mesylate) evaluating efficacy and safety for vasomotor symptoms in postmenopausal women have…
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause [Phase 2]
Phase 2 study evaluating eight-week efficacy and safety of Brisdelle (paroxetine mesylate) for vasomotor symptoms in menopause; results have…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women [Phase 3]
Phase 3 trial evaluating gabapentin extended-release for vasomotor symptoms (hot flashes) in postmenopausal women has completed and posted r…
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: Clinical Trial to Evaluate the Efficacy of FITOGYN Versus Placebo on the Vasomotor Symptomatology Associated With Menopause [Phase 4]
Phase 4 clinical trial evaluating the efficacy of FITOGYN versus placebo for vasomotor symptoms in postmenopausal women with moderate sympto…
-
CLINICAL_TRIALS trial_result · 2011-08-17Clinical Trial Update: Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women [Phase 3]
Pfizer completed a Phase 3 trial evaluating desvenlafaxine succinate for vasomotor symptoms in menopausal women, with results posted in 2011…